Bank of New York Mellon’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-22,977
| Closed | -$24K | – | 4375 |
|
|
2019
Q1 | $24K | Sell |
22,977
-561
| -2% | -$586 | ﹤0.01% | 4143 |
|
|
2018
Q4 | $18K | Hold |
23,538
| – | – | ﹤0.01% | 4165 |
|
|
2018
Q3 | $50K | Sell |
23,538
-1
| -0% | -$2 | ﹤0.01% | 4117 |
|
|
2018
Q2 | $54K | Sell |
23,539
-3,414
| -13% | -$7.83K | ﹤0.01% | 4077 |
|
|
2018
Q1 | $86K | Sell |
26,953
-1,754
| -6% | -$5.6K | ﹤0.01% | 4075 |
|
|
2017
Q4 | $117K | Buy |
28,707
+5,169
| +22% | +$21.1K | ﹤0.01% | 4045 |
|
|
2017
Q3 | $106K | Sell |
23,538
-1
| -0% | -$5 | ﹤0.01% | 3998 |
|
|
2017
Q2 | $78K | Sell |
23,539
-85,734
| -78% | -$284K | ﹤0.01% | 4069 |
|
|
2017
Q1 | $1.01M | Buy |
109,273
+5,305
| +5% | +$48.9K | ﹤0.01% | 3234 |
|
|
2016
Q4 | $802K | Buy |
103,968
+1,621
| +2% | +$12.5K | ﹤0.01% | 3382 |
|
|
2016
Q3 | $1.17M | Buy |
102,347
+12,528
| +14% | +$143K | ﹤0.01% | 3086 |
|
|
2016
Q2 | $1.11M | Buy |
89,819
+4,226
| +5% | +$52K | ﹤0.01% | 3071 |
|
|
2016
Q1 | $865K | Buy |
85,593
+21,037
| +33% | +$213K | ﹤0.01% | 3150 |
|
|
2015
Q4 | $1.46M | Buy |
64,556
+373
| +0.6% | +$8.41K | ﹤0.01% | 2901 |
|
|
2015
Q3 | $1.07M | Sell |
64,183
-7,979
| -11% | -$132K | ﹤0.01% | 3123 |
|
|
2015
Q2 | $1.62M | Buy |
72,162
+16,802
| +30% | +$378K | ﹤0.01% | 3057 |
|
|
2015
Q1 | $1.43M | Sell |
55,360
-9,751
| -15% | -$251K | ﹤0.01% | 3090 |
|
|
2014
Q4 | $1.42M | Buy |
65,111
+2,970
| +5% | +$64.7K | ﹤0.01% | 3086 |
|
|
2014
Q3 | $1.18M | Buy |
62,141
+9,422
| +18% | +$178K | ﹤0.01% | 3194 |
|
|
2014
Q2 | $1.23M | Buy |
52,719
+21,937
| +71% | +$511K | ﹤0.01% | 3194 |
|
|
2014
Q1 | $1.04M | Buy |
30,782
+11,553
| +60% | +$389K | ﹤0.01% | 3251 |
|
|
2013
Q4 | $567K | Buy |
+19,229
| New | +$567K | ﹤0.01% | 3525 |
|